⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VRTX News
Vertex Pharmaceuticals Inc
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
prnewswire.com
VRTX
CRSP
PRME
MDGL
Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence
prnewswire.com
EDIT
NTLA
RPTX
NVS
GILD
BMY
VRTX
CRL
OCGN
Vertex to Present at the 44 th Annual J.P. Morgan Healthcare Conference on January 12
businesswire.com
VRTX
Global Precision Medicine Market Growth Accelerates at 16.26% CAGR Through 2035 Expands Rapidly as AI, Genomic Testing, and Targeted Therapies Gain Momentum
globenewswire.com
NVDA
VRTX
Elevation Point Partners with Milemarker to Unify Data Across Growing Portfolio of Partner Firms and OCIO Business
globenewswire.com
ORLY
VRTX
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
globenewswire.com
ABBV
BMY
GILD
AMGN
AZN
LLY
BIIB
REGN
VRTX
XBI
IBB
CRSP
EDIT
NTLA
ABCL
NVS
MRK
PFE
JNJ
GSK
SNY
BTAI
INSM
HFA Architecture + Engineering Taps Sherwood Butler as Vice President
prnewswire.com
MRNA
BIIB
VRTX
NVS
SNY
PFE
CRSP
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
globenewswire.com
VRTX
NVO
CRSP
Vortex Named One of America’s Top 100 Most Loved Workplaces by The Wall Street Journal
globenewswire.com
VRTX
TreeFrog Therapeutics gibt Veränderungen im Vorstand bekannt Mark Rothera wird Chief Executive Officer und Vorstandsmitglied und soll die nächste Wachstumsphase vorantreiben
businesswire.com
SLN
VRTX
PTC